جست‌وجوی استاد و پژوهشگر

Ralf Zimmerمشاهده پروفایل

استاد

• Bioinformatics
• Systems Biology
• Machine Learning
• +۵ مورد دیگر

Ralf Zimmer is a Full Professor for Practical Informatics and Bioinformatics at Ludwig Maximilian University of Munich (LMU) since 2001, affiliated with the Department of Informatics in the Faculty of Mathematica, Informatics and Statistics. He concurrently serves as Head of Section III and Head of the Research Group Network Regulation and Modeling / Machine Learning at the Leibniz Institute for Food Systems Biology at TUM (Leibniz-LSB@TUM) in Freising, Germany. His academic foundation includes a Diploma with distinction in Computer Science, Applied Mathematics and Operations Research from the University of Bonn (1981-1986), followed by a summa cum laude Doctorate in Computer Science and Applied Mathematics from CAU Kiel in 1990, where he received dual honors: the CAU Dissertation Award and Best Dissertation Award. Zimmer's research pioneers the integration of bioinformatics, systems biology, and machine learning to decode molecular food-consumer interactions. His group develops causal system models for biological networks, validated through in silico simulations and multi-omics perturbation experiments (transcriptomics/proteomics). Core methodologies include network regulation modeling, algorithmic bioinformatics, and database construction linking food compounds to biochemical networks and cellular phenotypes, with translational goals for food and biotech innovation. His 14 most recent publications (2012-2024) reveal dominant trends in multi-omics immunology and cardiovascular research, featuring computational innovations for high-throughput data analysis. Key themes include host-pathogen dynamics (viral infections), inflammatory disease mechanisms (atherosclerosis), and methodological advances in proteomics/transcriptomics, consistently bridging fundamental bioinformatics with clinical applications. Major scientific recognitions include: CAU Dissertation Award and Best Dissertation Award (1990) Director of LMU's Informatics Department (2010-2012) DFG Review Board membership for biomedical foundations (2008-2016) Leadership of the DFG Bioinformatics Munich Center (2001-2008) Academic Senate election at LMU München (2011) Zimmer directs LMU/TUM's joint B.Sc./M.Sc. bioinformatics programs since 2001 as founding architect of the DFG-funded Bioinformatics Munich initiative. His educational leadership spans spokesperson roles for international training groups (IRTG RECESS), collaborative research centers (SFB1123 Atherosclerosis), and elite programs (Data Science, Munich Center for Machine Learning). Grant stewardship includes directing the DFG Bioinformatics Munich Center and shaping national funding policy via the DFG review board. At Leibniz-LSB@TUM, his research group pioneers databases connecting food compounds to cellular phenotypes through molecular networks, collaborating with Munich universities, clinics, and biotech partners to develop high-throughput sequencing/proteomics applications for future food and health innovations.

Tohru Fukaiمشاهده پروفایل

استاد

• Oxidative stress
• Cardiovascular disease
• Metabolic disease
• +۷ مورد دیگر

Tohru Fukai is a Professor and holds the Barbara A. Schnuck Endowed Chair in Translational Medicine at the Medical College of Georgia, Augusta University, where he serves in the Department of Pharmacology and Toxicology. His research is centered at the Vascular Biology Center, where he leads a productive laboratory investigating the molecular mechanisms of oxidative stress and dysfunctional copper metabolism in cardiovascular and metabolic diseases. Dr. Fukai earned his MD in 1988 and PhD in Medical Science in 1995, both from Kyushu University in Japan. Following his medical and doctoral training, he completed postdoctoral fellowship at Emory University School of Medicine in Atlanta from 1995-1999. His research focuses on oxidative stress in cardiovascular and metabolic disease pathogenesis, particularly investigating the role of extracellular SOD (ecSOD, SOD3) and copper transport proteins. His lab has pioneered research on copper transport proteins CTR1, Atox1, and ATP7A in regulating vascular function, demonstrating their critical roles in hypertension, vascular remodeling, inflammatory angiogenesis, atherosclerosis, and diabetes. Notably, his team discovered that copper chaperone Atox1 functions as a copper-dependent transcription factor regulating cell proliferation and inflammatory responses. Analysis of Dr. Fukai's recent publications reveals a strong focus on the intersection of redox signaling, copper metabolism, and vascular function. His work increasingly explores how oxidative stress and copper transport mechanisms contribute to conditions like diabetes, atherosclerosis, Alzheimer's disease, and ischemic injury. A prominent theme across his recent work is the role of protein modifications (particularly sulfenylation and SUMOylation) in regulating vascular responses to oxidative stress, with significant implications for therapeutic interventions. Dr. Fukai's scientific achievements have been recognized with numerous awards including the Barbara A. Schnuck Endowed Chair in Translational Medicine (2017), World Science Leaders in Human Biology Program (2021), and multiple Circulation Research Reviewer Awards. He has served on editorial boards for prestigious journals including Scientific Reports, Journal of Molecular and Cellular Cardiology, and American Journal of Physiology-Heart and Circulatory Physiology. As a mentor, Dr. Fukai has advised numerous graduate students and postdoctoral fellows, including several who have received AHA awards and trainee recognition. He serves on various committees including the VBC post-doc evaluation committee and the CNVAMC Subcommittee for Research Safety. His lab has secured significant funding, including a recent $11.3 million NIH grant for vascular disease research. Dr. Fukai leads an active research group at the Vascular Biology Center comprising senior research associates, assistant research scientists, postdoctoral fellows, and graduate students working collaboratively on multiple projects related to copper transport, redox signaling, and vascular disease mechanisms. His lab has made seminal contributions to understanding how copper transport proteins function as key regulators of vascular antioxidant enzymes and as unexpected signaling molecules in inflammatory disease processes.

• Oxygen Transport
• Vascular Physiology
• Skeletal Muscle Metabolism
• +۳ مورد دیگر

Russell Richardson is a tenured Professor at the University of Utah , holding joint appointments in the Department of Internal Medicine (Division of Geriatrics) and the Department of Exercise and Sport Science . He directs the Utah Vascular Research Laboratory (UVRL) at the Salt Lake VA Medical Center. Education: Fellowship (University of California San Diego), Doctoral Training (University of Utah), PhD (Colorado State University), MS (Loughborough University), PGCE (West London Institute of Higher Education) His research focuses on oxygen transport from air to tissue , with a current emphasis on the link between vascular and skeletal muscle function , particularly how oxidative stress regulates skeletal muscle metabolism and vascular control. He has authored numerous studies on aging, vascular dysfunction, and exercise hemodynamics. Recent publications highlight work on mitochondrial respiration, passive limb movement techniques, antioxidant interventions, and age-related vascular decline. His lab employs both in vivo and ex vivo methodologies to investigate these mechanisms. Collaborations span clinical and physiological domains, including studies in chronic obstructive pulmonary disease (COPD), heart failure, and breast cancer. His work integrates gerontology , exercise physiology , and vascular biology . Notable affiliations include the Salt Lake VA Medical Center and contributions to understanding the interplay between physical activity, aging, and vascular plasticity.

Cam Ha Tranمشاهده پروفایل

استادیار

• Neuroscience
• Cardiovascular Physiology
• Neurovascular Coupling
• +۴ مورد دیگر

Cam Ha Tran is an Assistant Professor in the Department of Physiology and Cell Biology at the University of Nevada, Reno, affiliated with the Institute of Neuroscience. Her research focuses on neurovascular unit interactions, particularly how blood flow regulation impacts brain function under health and disease conditions such as stroke and dementia. She employs advanced techniques like two-photon imaging, optogenetics, and electrophysiology to study astrocyte-endothelial communication and vascular reactivity. Education: PhD in Cardiovascular and Respiratory Sciences from the Cumming School of Medicine, University of Calgary (Canada); Master of Biomedical Technology and Bachelor of Science from the University of Alberta (Canada). Research emphasizes understanding how astrocytes and endothelial cells coordinate to maintain cerebral blood flow, with implications for neurological disorders. Her recent work explores TRPA1 channels in neurovascular coupling, astrocyte dysfunction in Alzheimer’s, and seizure-induced vascular changes. Techniques include in vivo imaging and chemogenetic approaches to dissect cellular mechanisms. Key contributions include uncovering astrocyte roles in functional hyperemia and identifying therapeutic targets for cerebrovascular diseases. Her lab’s findings bridge basic science and clinical applications, aiming to improve diagnostics and treatments for stroke and neurodegenerative conditions.

Kirsten Jungمشاهده پروفایل

استاد

• Bacterial Signal Transduction
• Stress Response Mechanisms
• Membrane Protein Structure-Function Analysis
• +۳ مورد دیگر

Prof. Dr. Kirsten Jung is a faculty member at the Department of Microbiology , Faculty of Biology , Ludwig Maximilian University of Munich . Her research focuses on bacterial signal transduction, stress response mechanisms, and systems biology approaches to understand microbial regulatory networks. Key research areas include stress-dependent gene expression in bacterial populations Structural and functional analysis of membrane-integrated receptors Metabolism-based chemical communication in bacteria Integration of experimental and computational systems biology Recent publications highlight her lab's work on Escherichia coli epitranscriptomic modifications under heat stress, m 5 C rRNA dynamics, and the role of RNA methylation in host-pathogen interactions. Collaborative studies address bacterial acid stress responses and their implications for antibiotic tolerance. Her interdisciplinary work bridges microbiology with ecological studies, as evidenced by research on biodiversity conservation in forest and urban ecosystems. Publications also demonstrate expertise in advanced imaging techniques (e.g., arterial spin labeling for glioma analysis) and bioinformatics approaches. Current advisees include Gloria Gessinger and Tania P. Gonzalez-Terrazas . She can be contacted at jung@lmu.de .

Samuel Fountainمشاهده پروفایل

استاد

• Pharmacology
• Ion Channels
• Cardiometabolic Physiology
• +۱۲ مورد دیگر

Professor Samuel Fountain is a leading academic in pharmacology at the University of East Anglia, where he serves as Chair of Pharmacology within the School of Biological Sciences. He holds additional leadership roles as Associate Pro-Vice-Chancellor of the UEA Doctoral College and has previously served as Associate Dean for Postgraduate Research and Director of the Biomedical Research Centre. He is actively supervising multiple PhD students and securing major research funding. BSc (Hons) Pharmacology, University of Leeds (1997–2000) MRC-funded PhD, University of Leeds (2000–2004) Wellcome Trust Research Associate, University of Manchester (2004–2008) BBSRC David Phillips Fellow, University of Leeds (2008–2010) Lecturer to Professor of Pharmacology, University of East Anglia (2010–present) His research focuses on the role of ion channels—particularly P2X receptors—in vascular and adipose tissues, with implications for cardiometabolic diseases. His work integrates pharmacology, physiology, and molecular biology to understand neurovascular and neuroadipose communication, receptor-ligand interactions, and drug discovery. He employs techniques such as pressure myography, patch-clamp electrophysiology, calcium imaging, and molecular modelling. The analysis of his recent publications reveals a strong emphasis on purinergic signalling, ion channel pharmacology, and autonomic control of blood vessels and fat tissue. His work bridges basic science with translational applications, particularly in hypertension, obesity, and metabolic syndrome. Collaborations with AstraZeneca, Merck, and the British Heart Foundation underscore the clinical and pharmaceutical relevance of his research. Notable scientific recognition includes the prestigious BBSRC David Phillips Fellowship. He also contributes to the academic community through editorial roles, including as Editor of Purinergic Signalling , and as a member of the British Pharmacological Society and The Physiological Society. Professor Fountain actively mentors postdoctoral researchers and PhD students, several of whom are funded by BBSRC, BHF, and AstraZeneca iCASE awards. His lab is supported by significant grants from the British Heart Foundation, BBSRC, and industry partners, enabling cutting-edge research in vascular and metabolic pharmacology. He leads multiple active projects on neurovascular transmission, purinergic control, and drug discovery for P2X receptors. His research group operates within the Cells and Tissues research theme at UEA and utilizes advanced experimental platforms including human tissue studies, high-throughput screening, and computational ligand docking. The lab fosters interdisciplinary collaboration between pharmacologists, physiologists, and clinicians, positioning it at the forefront of autonomic and metabolic research.

• Thrombosis
• Cardiovascular diseases
• Endothelial cell biology
• +۷ مورد دیگر

Associate Professor Freda Passam is a Clinical Academic Haematologist at Royal Prince Alfred Hospital, University of Sydney, specializing in thrombosis and haemostasis. She leads the Haematology Research Group at the Charles Perkins Centre, focusing on platelet biology, endothelial cell dysfunction, and translational research in cardiovascular diseases. Her work integrates basic science with clinical applications, including developing microfluidic technologies like the Endo-chip for thrombosis diagnosis and therapy screening. Education: MD and PhD in Greece (angiogenesis in Hodgkin’s lymphoma), postdoctoral training at UNSW and Harvard University. Research spans platelet hyperactivity in diabetes, immune thrombosis (e.g., HIT), and thiol isomerase inhibitors as antithrombotics. Collaborates globally with institutions like Harvard and the University of Utah. Research Interests: 1) Platelet biomarkers in diabetes-related cardiovascular risk; 2) Immune thrombosis diagnostics/therapies (e.g., Endo-chip); 3) Bone marrow-on-chip models for thrombopoiesis. Current projects include SEC61B regulation of calcium flux, endothelial thromboinflammation, and ERp5/ERp57 roles in platelet production. Grants: Over $6M in funding from NHMRC, MRFF, NSW Health, and industry partnerships. Notable awards include Sydney Nano Grand Challenge Award (2022) and SLHD VTE Stewardship Award (2020). Advising: Mentors over 6 PhD/master’s students in thrombosis research, emphasizing clinical/research integration. Teaching includes Sydney Medicine curriculum, bedside tutorials, and student engagement in lab activities. Labs/Teams: Haematology Research Group (Charles Perkins Centre), collaborations with Sydney Health Partners, Harvard, and international haematology groups. Develops technologies like the Endo-chip and bone marrow-on-chip models.

Gary K. Owensمشاهده پروفایل

استاد

• Cardiovascular Biology
• Atherosclerosis
• Smooth Muscle Cell Biology
• +۴ مورد دیگر

Dr. Gary K. Owens is a Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia , with a secondary appointment in the Department of Medicine, Division of Cardiology. He serves as Director of the Robert M. Berne Cardiovascular Research Center and leads groundbreaking research on vascular smooth muscle cell (SMC) dynamics in atherosclerosis. His work challenges conventional paradigms about SMC roles in plaque stability and thromboembolic events. Primary Affiliation: University of Virginia Key Titles: Robert M. Beirne Professor of Cardiovascular Research, Professor, Director of CVRC Research Themes include: Cardiovascular Biology Atherosclerosis Pathogenesis Smooth Muscle Cell Plasticity Epigenetic Regulation Inflammatory Signaling Tumor Metastasis Mechanisms Publication Trends (2015–2024) reveal expertise in Nature Medicine and Circulation studies, focusing on SMC gene regulation (Klf4/Oct4), plaque stability, and cross-talk between vascular cells and tumors. His work demonstrates that SMCs account for >80% of advanced lesion cells and that Klf4 inhibition reduces metastasis by >70%. Lab Leadership includes mentoring PhD students Anita Salamon and Victoria Milosek , alongside senior scientists and postdocs. Collaborations span with Dr. Gwen Randolph (Washington University) and Dr. Rosey Kaplan (NIH) on IL1β signaling and metastasis.

Gregory Dickمشاهده پروفایل

استاد پژوهشی

• Coronary Circulation
• Ion Channel Physiology
• Vascular Tone Regulation
• +۳ مورد دیگر

Gregory Dick, PhD, is a Research Professor in the Department of Physiology & Anatomy at the University of North Texas Health Science Center's College of Biomedical and Translational Sciences. His research focuses on ion channel regulation in coronary arteries, particularly how potassium channels control vascular tone under normal and pathological conditions (e.g., obesity, diabetes). He has led multiple NIH-funded projects exploring coronary vascular dysfunction and metabolic signaling. Education: Bachelor of Science in Physiology, Oklahoma State University Doctor of Philosophy in Physiology, University of Missouri Research Interests: Electro-metabolic signaling in coronary vasodilation Role of K+ channels in coronary blood flow regulation Impact of metabolic syndrome and obesity on cardiovascular health Vascular smooth muscle plasticity in disease states Key Projects (2024–2026): Role of potassium as a coronary metabolic vasodilator (Principal Investigator) Disentangling the Mechanisms of Coronary Dysfunction (Co-Investigator) Grants & Funding: NIH R01 Grant: Mineralocorticoid Receptor-Dependent Coronary Vascular Dysfunction in Obesity Multiple collaborative grants with University of Michigan and University of Missouri Collaborations: Active partnerships with institutions studying coronary autoregulation, metabolic syndrome, and swine models of cardiovascular disease.

Andrew Braunمشاهده پروفایل

استاد

• KCa Channels
• Nitric Oxide
• Calcium Signaling
• +۷ مورد دیگر

Andrew Braun is a Professor at the University of Calgary, affiliated with the Libin, Hotchkiss Brain Institute, and Snyder Institute. His research focuses on vascular physiology, particularly the role of potassium channels in regulating blood flow and pressure, with applications in diabetes and neurodegenerative diseases. He utilizes advanced techniques like patch clamping and arterial pressure myography. His work explores KCa channels , nitric oxide signaling , and calcium dynamics in vascular cells, aiming to develop novel therapies for endothelial dysfunction. He investigates how these channels affect myogenic tone , vasodilation , and coronary circulation in diseased states such as Type 2 Diabetes and Alzheimer's. The 15 most recent publications highlight his focus on pharmacological targeting of KCa channels to treat vascular complications in diabetes, aging, and atherosclerosis. Key subfields include platelet aggregation , genetic mutations in IP3 receptors , glycation effects on vascular function , and sex-dependent cerebrovascular defects . Contact information: Email abraun@ucalgary.ca. Administrative Assistant: Theresea Connolly (tconnoll@ucalgary.ca, 403-220-3018).

• General Cardiology
• Pulmonary Hypertension
• Heart Failure
• +۴ مورد دیگر

John J. Ryan is a Professor of Medicine in the Division of Cardiovascular Medicine at the University of Utah School of Medicine , specializing in General Cardiology and Pulmonary Hypertension . He holds adjunct associate professorships in Family & Preventive Medicine, Orthopaedics, and Radiology & Imaging Sciences. Dr. Ryan’s research focuses on heart failure with preserved ejection fraction , pulmonary vascular disease , and right ventricular function . His work explores statin therapy , microvascular dysfunction , and novel treatments for pulmonary hypertension . His publications emphasize cardiovascular outcomes in pulmonary hypertension, exercise physiology in heart failure, and digital health tools. He is board-certified in Advanced Heart Failure & Transplant Cardiology , Cardiovascular Disease , and Echocardiography . Clinically, he practices at the University of Utah Hospital , with consistently high patient satisfaction scores ( 4.9/5 ). His academic training includes M.D. from University College Cork , followed by residency at Boston Medical Center and fellowships at the University of Chicago Medical Center .

John Eberthمشاهده پروفایل

دانشیار

• Cardiovascular Engineering
• Biomechanics
• Mechanobiology
• +۹ مورد دیگر

Dr. John F. Eberth is an Associate Professor at Drexel University's School of Biomedical Engineering, Science and Health Systems. As a cardiovascular engineer with expertise in mechanical controls, continuum biomechanics, and hydrogel-based extracellular matrix mimetics, he leads the Applied Biomechanics and Mechanobiology Lab (ABML) to investigate vascular behavior under mechanical stimuli. PhD in Biomedical Engineering from Texas A&M University (2008) MS in Mechanical Engineering from Clemson University (2004) BS in Mechanical Engineering from Clarkson University (2001) His research focuses on vascular pathology and mechanobiology, including: Aortopathy and aneurysm mechanics Endothelial dysfunction and arterial stiffening Hydrogel-based vascular grafts Calcification chelation therapy Coronary artery disease Perfusion tissue culture Recent publications demonstrate expertise in vascular imaging techniques, mechanical modeling, and therapeutic interventions. Key themes include drug-coated balloon development, collagen fiber mechanics, and bioreactor systems for vascular conditioning.

• Sleep Medicine
• Respiratory Diseases
• Allergy
• +۴ مورد دیگر

Eva Lindberg is a Professor at the Department of Medical Sciences , Uppsala University , specializing in Lung, Allergy, and Sleep Research . She has contributed extensively to understanding the interplay between sleep-related disorders and respiratory/cardiovascular health. Research Themes : Sleep apnea, COPD, asthma, cardiometabolic risks, population-based studies. Key Collaborations : RHINESSA, SCAPIS, MUSTACHE cohorts. Her 2025 publications focus on cardiovascular consequences of sleep apnea, proteomic associations in lung disease, and cancer risks linked to nocturnal breathing disorders. Earlier work (2024–2022) examines obesity, physical activity, and environmental factors in sleep and respiratory health. Eva Lindberg is actively involved in clinical trials for sleep apnea interventions, including behavioral medicine and device-based therapies. She emphasizes sex-specific differences in sleep disorder diagnosis and outcomes.

Christopher J. Cooperمشاهده پروفایل

استاد

• Cardiovascular Medicine
• Interventional Cardiology
• Renovascular Hypertension
• +۴ مورد دیگر

Christopher J. Cooper, M.D., is Distinguished University Professor of Medicine at the University of Toledo, Ohio, where he also served as Dean of the College of Medicine (2014-2024), CEO of University of Toledo Physicians, and Executive Vice-President for Clinical Affairs. Triple-board-certified in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology, he directs the UT Clinical Coordinating Center and has led national randomized trials on renal-artery stenosis. Education & Training: B.A. magna cum laude in Biology (Philosophy minor), Wittenberg University, 1985 M.D., University of Cincinnati College of Medicine, 1988 — Valedictorian, Alpha Omega Alpha Internship & Residency, Brigham and Women’s Hospital / Harvard Medical School, 1988-1991 Cardiology Fellowship, Brigham and Women’s Hospital, 1991-1994 Harvard School of Public Health, Clinical Effectiveness Program, 1992 Research Focus: Cooper’s group investigates renovascular hypertension, renal-artery stenosis, and cell-based therapies for vascular disease. As PI of the NIH-funded CORAL trial and multiple industry grants, he has published pivotal papers defining when renal stenting benefits patients and elucidating inflammatory and signaling pathways that couple renal artery narrowing to hypertension and renal failure. Recent work integrates large-scale clinical outcomes databases with mechanistic studies on Na/K-ATPase signaling, microRNA regulation of cardiac fibrosis, and biomarkers such as CD40-ligand in renovascular disease. Honors & Awards: Best Doctors in America — multiple years (2002-2014) America’s Top Doctors, Castle Connolly — consecutive listings (2006-2015) College of Medicine Award for Excellence in Clinical Research, UT (2008) Elected Fellow, American Heart Association Council on High Blood Pressure Research (2004) Valedictorian & Alpha Omega Alpha, Univ. of Cincinnati (1988) Leadership & Grants: Cooper has held continuous NIH and industry funding for multicenter trials; he founded and directs the UT Clinical Coordinating Center, overseeing regulatory, data, and biostatistical cores for national studies. His administrative leadership spans Department Chair, Heart & Vascular Center Director, and Dean of the College of Medicine, while maintaining an active interventional cardiology practice. Laboratory & Teams: He leads the Cooper Renal & Vascular Research Group within the UT Cardiovascular Research Institute, mentoring faculty, fellows, and graduate students in translational protocols that bridge molecular cardiology, interventional imaging, and large pragmatic trials.

Mansoureh Eghbaliمشاهده پروفایل

استاد

• Pulmonary Hypertension
• Myocardial Ischemia-Reperfusion Injury
• Sex Differences in Cardiovascular Disease
• +۳ مورد دیگر

Mansoureh Eghbali, PhD, is a Professor in the Department of Anesthesiology at the David Geffen School of Medicine, University of California, Los Angeles. Her research program investigates molecular mechanisms of cardiovascular and pulmonary diseases with emphasis on sex-specific pathophysiology. She leads an active NIH-funded laboratory focused on pulmonary hypertension, myocardial ischemia-reperfusion injury, and the role of RNA-binding proteins in vascular remodeling. Her research integrates multiomics approaches to explore: Sex chromosome influences (Y-gene Uty) in pulmonary vascular protection MicroRNA regulation of cardiac fibrosis and calcification (e.g., miR-129-5p/Asporin axis) Gut-heart-lung interactions in diet-induced pulmonary hypertension Endothelial subpopulations (TM4SF1+) in disease progression Analysis of her recent publications reveals strong emphasis on: Integrative multiomics in vascular diseases Sex differences in drug responses Novel therapeutic targeting of RNA-binding proteins Cross-organ communication in cardiopulmonary pathologies She directs multiple NIH grants including: R01HL159865: Role of Chromosome Y gene, Uty (2021-2025) R01HL147586: Role of miR125 in pulmonary hypertension (2019-2023) R01HL129051: Role of miR193 in oxidized lipid-induced PH (2016-2021) R01HL131182: Epigenetic regulation by X chromosome (2016-2021)